160 related articles for article (PubMed ID: 2147864)
21. Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing PRAME as a specific discriminating marker.
McElwaine S; Mulligan C; Groet J; Spinelli M; Rinaldi A; Denyer G; Mensah A; Cavani S; Baldo C; Dagna-Bricarelli F; Hann I; Basso G; Cotter FE; Nizetic D
Br J Haematol; 2004 Jun; 125(6):729-42. PubMed ID: 15180862
[TBL] [Abstract][Full Text] [Related]
22. Pan myeloid antigen-negative pediatric acute megakaryoblastic leukemia.
Cetin N; Lorsbach RB
Pediatr Blood Cancer; 2014 Nov; 61(11):2089-91. PubMed ID: 24962432
[TBL] [Abstract][Full Text] [Related]
23. Pseudoleukemia in Down's syndrome. Analysis of immunophenotype and gene rearrangement.
Domenico DR; Dizikes GJ; Melnyk AR; Bird ML; Suarez CR; Schumacher HR
Am J Clin Pathol; 1989 Jun; 91(6):709-14. PubMed ID: 2524966
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia.
Sato T; Fuse A; Eguchi M; Hayashi Y; Ryo R; Adachi M; Kishimoto Y; Teramura M; Mizoguchi H; Shima Y
Br J Haematol; 1989 Jun; 72(2):184-90. PubMed ID: 2527057
[TBL] [Abstract][Full Text] [Related]
25. Cell surface phenotyping of megakaryoblasts.
Koike T; Aoki S; Maruyama S; Narita M; Ishizuka T; Imanaka H; Adachi T; Maeda H; Shibata A
Blood; 1987 Mar; 69(3):957-60. PubMed ID: 3028539
[TBL] [Abstract][Full Text] [Related]
26. Ultrastructural investigation of DNA in megakaryoblastic leukemia by using osmium-ammine-B: comparison with several types of leukemia.
Ohwada Y; Eguchi M
Med Oncol Tumor Pharmacother; 1993; 10(3):117-24. PubMed ID: 8264256
[TBL] [Abstract][Full Text] [Related]
27. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.
Bercovich D; Ganmore I; Scott LM; Wainreb G; Birger Y; Elimelech A; Shochat C; Cazzaniga G; Biondi A; Basso G; Cario G; Schrappe M; Stanulla M; Strehl S; Haas OA; Mann G; Binder V; Borkhardt A; Kempski H; Trka J; Bielorei B; Avigad S; Stark B; Smith O; Dastugue N; Bourquin JP; Tal NB; Green AR; Izraeli S
Lancet; 2008 Oct; 372(9648):1484-92. PubMed ID: 18805579
[TBL] [Abstract][Full Text] [Related]
28. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
Simon JH; Tebbi CK; Freeman AI; Brecher ML; Green DM; Sandberg AA
Cancer; 1987 Nov; 60(10):2515-20. PubMed ID: 2959356
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and Down's syndrome. A Pediatric Oncology Group study.
Ragab AH; Abdel-Mageed A; Shuster JJ; Frankel LS; Pullen J; van Eys J; Sullivan MP; Boyett J; Borowitz M; Crist WM
Cancer; 1991 Feb; 67(4):1057-63. PubMed ID: 1825025
[TBL] [Abstract][Full Text] [Related]
30. Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome.
Hama A; Yagasaki H; Takahashi Y; Nishio N; Muramatsu H; Yoshida N; Tanaka M; Hidaka H; Watanabe N; Yoshimi A; Matsumoto K; Kudo K; Kato K; Horibe K; Kojima S
Br J Haematol; 2008 Mar; 140(5):552-61. PubMed ID: 18275433
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome.
Hayashi Y; Eguchi M; Sugita K; Nakazawa S; Sato T; Kojima S; Bessho F; Konishi S; Inaba T; Hanada R
Blood; 1988 Jul; 72(1):15-23. PubMed ID: 2968822
[TBL] [Abstract][Full Text] [Related]
32. Acute lymphoblastic leukemia following preleukemic syndromes in adults.
Escudier SM; Albitar M; Robertson LE; Andreeff M; Pierce S; Kantarjian HM
Leukemia; 1996 Mar; 10(3):473-7. PubMed ID: 8642864
[TBL] [Abstract][Full Text] [Related]
33. Peroxidase-negative and myelomonocytic antigen-positive acute leukemia.
Okawa H; Nagasawa M; Morio T; Takase K; Tanaka K; Yata J; Dan K; Nomura T; Sakamaki H; Onozawa Y
Int J Hematol; 1992 Apr; 55(2):165-71. PubMed ID: 1324747
[TBL] [Abstract][Full Text] [Related]
34. CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome.
Savaşan S; Buck S; Raimondi SC; Becton DL; Weinstein H; Chang M; Ravindranath Y
Leuk Lymphoma; 2006 Oct; 47(10):2076-83. PubMed ID: 17071479
[TBL] [Abstract][Full Text] [Related]
35. Transient myeloproliferative disorder in Down's syndrome: three cases with megakaryocytic markers.
Sartori PC; Darbyshire PJ
Pediatr Hematol Oncol; 1991; 8(2):139-45. PubMed ID: 1830754
[TBL] [Abstract][Full Text] [Related]
36. Acute leukemia in Down's syndrome.
Athale UH; Nair R; Kadam P; Pai SK; Advani SH
Indian Pediatr; 1990 Jan; 27(1):73-5. PubMed ID: 2141827
[No Abstract] [Full Text] [Related]
37. Acute megakaryoblastic leukemia in children identified by immunological marker studies.
Hirt A; Luethy AR; Mueller B; Gugler E; Wagner HP
Am J Pediatr Hematol Oncol; 1990; 12(1):27-33. PubMed ID: 2178458
[TBL] [Abstract][Full Text] [Related]
38. Multicolor flow-cytometric, morphologic, and clonogenic analysis of marrow CD10-positive cells in children with leukemia in remission or nonmalignant diseases.
Fukushima T; Sumazaki R; Koike K; Tsuchida M; Matsui A; Nakauchi H
J Pediatr Hematol Oncol; 1998; 20(3):222-8. PubMed ID: 9628433
[TBL] [Abstract][Full Text] [Related]
39. Elevated common acute lymphoblastic leukemia antigen expression in pediatric immune thrombocytopenic purpura.
Cornelius AS; Campbell D; Schwartz E; Poncz M
Am J Pediatr Hematol Oncol; 1991; 13(1):57-61. PubMed ID: 1827572
[TBL] [Abstract][Full Text] [Related]
40. Cytoplasmic GpIIb-IIIa and cytokine secretion by blasts in a case of megakaryoblastic transformation of essential thrombocythemia.
Selleri C; Alfinito F; Del Vecchio L; Luciano L; De Renzo A; Rotoli B
Leuk Lymphoma; 1993 Aug; 10(6):497-500. PubMed ID: 8401187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
